# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-26-137931
Filing Date
2026-04-01
Accepted
2026-04-01 16:16:27
Documents
1
Period of Report
2025-12-31
Effectiveness Date
2026-04-01

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | vktx-2026-04-01-ars.pdf | ARS | 927604
| Complete submission text file | 0001193125-26-137931.txt |  | 1278605

Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

EIN.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-37355 | Film No.: 26828437
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)